Press release
Lipid-lowering Drugs Market Will Estimated to Touch USD 42.5 Billion by 2031 | TMR Research
Lipid-lowering Drugs market is estimated to attain a valuation of US$ 42.5 Bn by the end of 2031, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of 3.4% during the forecast period, 2023-2031
Get a Sample Copy of the Lipid-lowering Drugs Market Research Report -https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=85507
The significant players operating in the global Lipid-lowering Drugs market are- Sanofi, Pfizer, Inc., GlaxoSmithKline plc, Novartis AG, Merck & Co., Inc., Amgen Inc., Takeda Pharmaceutical Company Limited, Sun Pharmaceutical Industries Ltd., AbbVie, Inc., Viatris (Mylan N.V.), AstraZeneca PLC, and Dr. Reddy's Laboratories Ltd.
Overview of the Lipid-Lowering Drugs Market
Lipid-lowering drugs, also known as antihyperlipidemic agents, are medications used to lower lipid levels in the blood, primarily to reduce cholesterol. They are essential in the prevention and management of cardiovascular diseases such as heart attacks and strokes. The market includes statins, bile acid sequestrants, cholesterol absorption inhibitors, fibrates, PCSK9 inhibitors, and other novel agents. As cardiovascular diseases continue to be a leading cause of mortality worldwide, the demand for effective lipid-lowering therapies is expected to increase.
Recent Developments in Lipid-Lowering Drugs
Recent advancements in the lipid-lowering drugs market include the development of new formulations with improved efficacy and safety profiles, increased research into combination therapies, and the introduction of novel agents such as PCSK9 inhibitors. These innovations are enhancing the effectiveness and accessibility of lipid-lowering drugs.
Key Developments:
PCSK9 Inhibitors: The introduction of PCSK9 inhibitors has provided a new class of potent lipid-lowering drugs that significantly reduce LDL cholesterol levels and improve cardiovascular outcomes.
Combination Therapies: Increased research into the use of lipid-lowering drugs in combination with other cardiovascular medications is optimizing treatment protocols and enhancing efficacy.
Gene Therapy: Ongoing research into gene therapy approaches for lipid disorders holds promise for future breakthroughs in the management of hyperlipidemia.
Key Drivers of the Lipid-Lowering Drugs Market
Several factors are propelling the growth of the lipid-lowering drugs market. These include the rising prevalence of cardiovascular diseases, technological advancements in drug formulations, increased healthcare spending, and supportive government initiatives.
Key Drivers:
Increasing Prevalence of Cardiovascular Diseases: The growing incidence of cardiovascular diseases, driven by factors such as unhealthy diets, sedentary lifestyles, and aging populations, is fueling market growth.
Technological Advancements: Innovations in pharmaceutical formulations are enhancing the efficacy, safety, and patient compliance of lipid-lowering drugs.
Rising Healthcare Spending: Increased spending on healthcare, particularly in emerging markets, is boosting the demand for effective cardiovascular treatments such as lipid-lowering drugs.
Government Initiatives: Supportive government policies and programs aimed at reducing the burden of cardiovascular diseases and promoting heart health are promoting market growth.
Buy this Premium Research Report: - https://www.transparencymarketresearch.com/checkout.php?rep_id=85507<ype=S
Market Segmentation -
Drug Class
Statins & Combination
PCSK9 Inhibitors
Bile Acid Sequestrants
Fibrates
Cholesterol Absorption Inhibitors
Others
Indication
Hypercholesterolemia
Coronary Artery Disease
High Triglycerides
Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
This Report lets you identify the opportunities in Lipid-lowering Drugs Market by means of a region:
North America (the United States, Canada, and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, and Southeast Asia (Indonesia, Thailand, Philippines, Malaysia, and Vietnam))
South America (Brazil etc.) The Middle East and Africa (North Africa and GCC Countries)
More Trending Reports by Transparency Market Research -
Brine Concentration Technology Market : https://www.globenewswire.com/en/news-release/2024/03/01/2838556/32656/en/Brine-Concentration-Technology-Market-to-Reach-USD-20-4-billion-Surging-at-a-CAGR-of-4-3-by-2031-Transparency-Market-Research-Inc.html
Biopharmaceutical Fermentation Systems Market: https://www.globenewswire.com/en/news-release/2024/03/01/2838573/32656/en/Biopharmaceutical-Fermentation-Systems-Market-Projected-to-Reach-USD-52-6-billion-by-2031-with-a-CAGR-of-9-5-Report-by-Transparency-Market-Research-Inc.html
About Us Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.
Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.
𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐔𝐬
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Lipid-lowering Drugs Market Will Estimated to Touch USD 42.5 Billion by 2031 | TMR Research here
News-ID: 3532174 • Views: …
More Releases from Transparency Market Research
Functional Coffee Market Expanding at 7.6% CAGR Through 2035 - By Product Type / …
The global functional coffee market was valued at US$ 21.5 Bn in 2024 and is projected to reach US$ 48.1 Bn by 2035, expanding at a compound annual growth rate (CAGR) of 7.6% from 2025 to 2035. This steady growth trajectory reflects the strong convergence of coffee consumption habits with rising demand for functional and wellness-oriented beverages. Functional coffee has transitioned from a niche category to a mainstream product offering,…
Global Electric Face Cleanser Market Poised for Robust Growth, projected to Reac …
The global electric face cleanser market is witnessing a transformative growth phase as consumers increasingly integrate advanced skincare technologies into their daily routines. Valued at USD 9.8 billion in 2025, the market is projected to expand significantly and reach USD 23.6 billion by 2036, growing at a healthy compound annual growth rate (CAGR) of 8.6% from 2026 to 2036. This growth trajectory underscores the rising importance of personal care technology,…
Asthma and COPD Drugs Market to Reach US$ 82.2 Billion by 2036, Growing at 5.7% …
The global asthma and COPD drugs market demonstrated strong fundamentals in 2025, with a valuation of US$ 44.7 Bn, reflecting the essential and recurring nature of respiratory therapeutics. Supported by a growing patient base and continuous pharmaceutical innovation, the market is projected to reach US$ 82.2 Bn by 2036, expanding at a compound annual growth rate (CAGR) of 5.7% from 2026 to 2036.
This growth trajectory highlights the increasing reliance on…
Low-Alcohol Beverages Market Outlook 2035: Global Industry Set to Expand from US …
The global low-alcohol beverages market is undergoing a structural transformation as consumers increasingly prioritize health, moderation, and mindful drinking without sacrificing taste or social experiences. Valued at US$ 2.1 billion in 2024, the market is projected to reach US$ 4.6 billion by 2035, expanding at a healthy CAGR of 7.5% from 2025 to 2035. This sustained growth reflects changing lifestyle preferences, generational shifts in alcohol consumption, and continuous innovation by…
More Releases for Drug
Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming…
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage
Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic…
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights:
* Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029
* Global and Regional Antibody Drug Conjugate Market Insight
* Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023
* Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight
* Insight On Antibody Drug Conjugates In Clinical Trials: > 550…
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
